WCN26-8154 Development of a Humanized 3D Bioprinted Model for Studying Kidney Fibrosis and Drug Response

Read full text Summarise with VIRAT
Authors: Carlos Mota
Cited by: 0

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

Chronic kidney disease (CKD) is a global health burden, often culminating in kidney fibrosis, a pathological process marked by excessive extracellular matrix (ECM) deposition and progressive loss of renal function. Fibrosis primarily affects the tubulointerstitium, disrupting homeostasis between tubules, capillaries, and surrounding tissue. Current in vivo and 2D in vitro models fail to recapitulate the complexity of human kidney fibrosis, limiting therapeutic development. There is a pressing need for physiologically relevant humanized 3D models that align with the 3Rs principles and enable disease progression studies and drug screening.

Fields of Study & Subjects

3D Printing in Biomedical Research Chronic Kidney Disease and Diabetes Tissue Engineering and Regenerative Medicine

Publication details

Journal / source
Kidney International Reports
Volume
11
Issue
4
Pages
105956–105956
Publication date
25 March 2026
Language
EN